Chris Ostergaard wrote -Over the last decade, a few of my family members have died or suffered from cancer. I wanted to do something significant to help find cures. To that end, the primary goal for running the San Francisco Marathon is to raise funds for Stand Up To Cancer.
Cancer kills 1,500 Americans every day. That’s one person every minute. But we can change these staggering statistics if we stand up to cancer TOGETHER.
What is the goal of Stand Up To Cancer?
Simply put, Stand Up To Cancer’s goal is to end cancer’s reign as a leading cause of death by raising funds to accelerate research that will help transform cancer from a disease that takes far too many lives to one people survive.
SU2C is founded on the belief that in the field of cancer research there is a solid foundation and sufficient understanding of the basic science of cancer, and with the technologies available, now is the time to take that understanding to the next level by translating this knowledge to the clinic—to real advances in patient care and cancer prevention.
Stand Up To Cancer’s innovative approach to research is designed to eliminate barriers that have traditionally inhibited creativity and collaboration by enabling the best and brightest investigators from leading institutions across the country and internationally to work together. In 2009, SU2C awarded its first grants to five of these “Dream Teams,” which are investigating promising new therapies for cancer patients and advancing efforts in cancer prevention research. Today, fourteen teams of incredible scientists are already hard at work, driven by the same principles that laid the foundation of the Stand Up To Cancer model: collaboration, innovation, acceleration, targeted therapy, and translational research. Stand Up To Cancer has also awarded Innovative Research Grants to 26 individual young scientists who are pursuing high-risk, high-impact cancer research, which is often not supported by conventional funding sources. For more information about SU2C, please visit www.standup2cancer.org.